2012-10-10 09:28:06 - Fast Market Research recommends "Eurocine Vaccines AB - Product Pipeline Review - 2012" from Global Markets Direct, now available

Global Market Direct's pharmaceuticals report, "Eurocine Vaccines AB - Product Pipeline Review - 2012" provides data on the Eurocine Vaccines AB's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Eurocine Vaccines AB's corporate website, SEC filings, investor presentations and featured press releases, both from Eurocine Vaccines AB and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Eurocine Vaccines AB - Brief Eurocine Vaccines AB overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Eurocine Vaccines AB human

therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Eurocine Vaccines AB with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Eurocine Vaccines AB's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468638_eurocine_vaccines_ab_product_pipeline ..


Reasons to buy

* Evaluate Eurocine Vaccines AB's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Eurocine Vaccines AB in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Eurocine Vaccines AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Eurocine Vaccines AB.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Eurocine Vaccines AB and identify potential opportunities in those areas.

Report Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Eurocine Vaccines AB Snapshot
Eurocine Vaccines AB Overview
Key Information
Key Facts
Eurocine Vaccines AB - Research and Development Overview
Key Therapeutic Areas
Eurocine Vaccines AB - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Eurocine Vaccines AB - Pipeline Products Glance
Eurocine Vaccines AB Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Eurocine Vaccines AB - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Eurocine Vaccines AB - Drug Profiles
Immunose FLU
Product Description
Mechanism of Action
R&D Progress
Nasal Pneumococcal Vaccine
Product Description
Mechanism of Action
R&D Progress
Eurocine Vaccines AB - Pipeline Products by Route of Administration
Eurocine Vaccines AB - Recent Pipeline Updates
Eurocine Vaccines AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Eurocine Vaccines AB, Recent Developments
Eurocine Vaccines AB- Press Release
Jan 04, 2012: Eurocine Vaccines, Bionor Pharma And Oslo University Announce Full Enrollment Of Nasal Immunization Study Of Vacc4x And Endocine
Dec 03, 2009: Eurocine Vaccines' Clinical Trial Fully Recruited
Oct 07, 2009: Eurocine Vaccines Begins Nasal Influenza Vaccine Study In Humans
Financial Deals Landscape
Eurocine Vaccines AB, Deals Summary
Eurocine Vaccines AB, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Eurocine Vaccines Enters Into Collaboration With HeliCure
Equity Offering
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Eurocine Vaccines AB, Key Information
Eurocine Vaccines AB, Key Facts
Eurocine Vaccines AB - Pipeline by Indication, 2012
Eurocine Vaccines AB - Pipeline by Stage of Development, 2012
Eurocine Vaccines AB - Monotherapy Products in Pipeline, 2012
Eurocine Vaccines AB - Phase I, 2012
Eurocine Vaccines AB - Pre-Clinical, 2012
Eurocine Vaccines AB - Pipeline By Route of Administration, 2012
Eurocine Vaccines AB - Recent Pipeline Updates, 2012
Eurocine Vaccines AB, Subsidiaries
Eurocine Vaccines AB, Deals Summary
Eurocine Vaccines Enters Into Collaboration With HeliCure
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million

List of Figures
Eurocine Vaccines AB - Pipeline by Indication, 2012
Eurocine Vaccines AB - Pipeline by Stage of Development, 2012
Eurocine Vaccines AB - Monotherapy Products in Pipeline, 2012

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.